In which country is Forallbio Inc., registered?
Forallbio Inc., has established an offshore holding structure in the Cayman Islands, a global operations headquarters in Hong Kong, and also established offices in Taiwan, China, Malaysia and Vietnam.
Which is the independent audit firm of Forallbio Inc., ?
Forallbio Inc. has hired an audit firm with 30 years of experience in Taiwan to handle domestic and foreign accounting matters. Hong Kong companies will also hire international accounting firms.
What is the development layout of Forallbio Inc., ?
Forallbio’s products have been taken in more than 20 countries and it is expected to expand to 30 by the end of 2020. In terms of developing genetic protein tests, Fuzhong Biomedical expects to cooperate with Chinese and Asian hospitals by the end of 2020 to reach 1,000 tests per year.
What is the research and development strength of Forallbio Inc., ? What are the main R & D directions?
Looking forward to the new decade of 2020, Forallbio Inc., will continue to focus on the research of cancer and telomere structure, and launch patented blood tests for more accurate and popular multi-molecular protein therapy assessment and monitoring. In terms of anti-aging and anti-cancer, Fuzhong Biomedicine will develop more personalized and routine health care methods to keep many people away from illness.
What are the current strategic partners of Forallbio Inc., ?
Forallbio Inc., is currently about to establish strategic partnerships in many countries in Europe and Asia, including Germany, Switzerland, China, Japan, Malaysia and Vietnam. The key goal is to find and combine more high-quality and scientific treatment methods to establish a one-stop health care coverage system.
When will Forallbio Inc., conduct the next round of financing?
Stepping into 2020, Forallbio Prospects will show international investors the most sustainable side. In addition to applying for membership of the United Nations Compact Enterprise, Fuzhong Biomedical will continue to expand overseas cooperation. The financing plan is expected to be completed by the first quarter of 2020.